BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11149026)

  • 1. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV.
    Sharafeldin MA; Suef RA; Mousa AA; Ziadah DH; Farag MMS
    Pathol Res Pract; 2024 Jun; 258():155327. PubMed ID: 38692084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
    Cai X; Peng S; Xiao X; Huang Z; Zhang P
    Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
    Gopal P; Yopp AC; Waljee AK; Chiang J; Nehra M; Kandunoori P; Singal AG
    Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H
    Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases.
    Miao X; Peng C; Yan F; Guo X; Xia L; Song Q; An X; Wu G
    J Infect Dev Ctries; 2024 Apr; 18(4):618-626. PubMed ID: 38728647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response.
    Chida T; Ohta K; Noritake H; Matsushita M; Murohisa G; Kageyama F; Sasada Y; Oyaizu T; Tsugiki M; Tamakoshi K; Nakajima T; Suda T; Kawata K
    Sci Rep; 2024 May; 14(1):10864. PubMed ID: 38740815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
    Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma.
    Tyson GL; Duan Z; Kramer JR; Davila JA; Richardson PA; El-Serag HB
    Clin Gastroenterol Hepatol; 2011 Nov; 9(11):989-94. PubMed ID: 21820396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.
    Patel J; Yopp A; Waljee AK; Singal AG
    J Clin Gastroenterol; 2016 Feb; 50(2):175-9. PubMed ID: 26125462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection.
    Watanabe T; Tokumoto Y; Joko K; Michitaka K; Horiike N; Tanaka Y; Tada F; Kisaka Y; Nakanishi S; Yamauchi K; Yukimoto A; Nakamura Y; Hirooka M; Abe M; Hiasa Y
    J Med Virol; 2020 Dec; 92(12):3507-3515. PubMed ID: 32374470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in pregnancy: A systematic review.
    Marasciulo F; Passerini I; Fichera A; Ferrari F; Odicino FE; Prefumo F
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):653-659. PubMed ID: 37533304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
    Zhang SY; Lin BD; Li BR
    FEBS Open Bio; 2015; 5():240-4. PubMed ID: 25870783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.
    Morgan TR; Osann K; Bottiglieri T; Pimstone N; Hoefs JC; Hu KQ; Hassanein T; Boyer TD; Kong L; Chen WP; Richmond E; Gonzalez R; Rodriguez LM; Meyskens FL
    Cancer Prev Res (Phila); 2015 Sep; 8(9):864-72. PubMed ID: 26130251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.
    Di Carlo I; Mannino M; Toro A; Ardiri A; Galia A; Cappello G; Bertino G
    World J Surg Oncol; 2012 May; 10():79. PubMed ID: 22559879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
    Bae JS; Park SJ; Park KB; Paik SY; Ryu JK; Choi CK; Hwang TJ
    Korean J Intern Med; 2005 Mar; 20(1):80-5. PubMed ID: 15906959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
    Mehinovic L; Islamagic E; Husic-Selimovic A; Kurtovic-Kozaric A; Vukobrat-Bijedic Z; Suljevic D
    Open Access Maced J Med Sci; 2018 Sep; 6(9):1668-1673. PubMed ID: 30337985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of serum STIP1 in HCC and AFP-negative HCC.
    Sun H; Liu N; Lou J
    Lab Med; 2024 May; ():. PubMed ID: 38780206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC).
    Lu F; Ott C; Bista P; Lu X
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy.
    Bracco C; Gallarate M; Badinella Martini M; Magnino C; D'Agnano S; Canta R; Racca G; Melchio R; Serraino C; Polla Mattiot V; Gollè G; Fenoglio L
    World J Gastrointest Oncol; 2024 Mar; 16(3):761-772. PubMed ID: 38577451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.